Last updated on December 2019

A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)


Find a site near you

Start Over

Saitama Cancer Center

Saitama, Japan
2.09miles
  Connect »